Hypersensitivity to the active substance, or to any of the excipients.
Second and third trimesters of pregnancy.
The concomitant use of Irbesartan with aliskerin-containing products is contraindicated in patients with diabetes mellitus or renal impairment (glomerular filtrate rate (GFR) <60 ml/min/1.73m2.